Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Why Index Funds Exist Explained: Learn the rationale behind index funds, their historical performance, and how they simplify investing.
22,049 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
As geopolitical tensions rise, investors reassess defense exposure. This report examines the weapons that changed war...
A major fund is doubling down on Lionsgate Studios as shares skyrocket. Learn what know about this bet, the strategy ...
SpaceX going public soon would shake investor interest in the space economy. This guide shows how to position yoursel...
The U.S. Treasury must refinance about $8 trillion in debt over the next year, a record load that market watchers say...
A wave of quantum funding is moving beyond labs to big-name backers. BlackRock, Nvidia, and Temasek are leading a sur...
A Palestinian activist has filed a federal lawsuit accusing a network of conservative groups of coordinating to silen...
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
A billionaire hedge fund manager shows the power of high-conviction bets in AI. This article breaks down Ackman'...
Investors eye the long end of the curve as Kevin Warsh's QT stance shifts income dynamics. Forget utility dividends. ...
A recent health update about Clive Davis returning home after hospitalization offers a powerfulFinance lesson: prepar...
Retirees face a shifting rate landscape. This guide explains how a possible 2026 rate rise could affect income, withd...